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immunosensor for celiac disease clinical diagnosis
Marta M. P. S. Neves,abc Mar´ıa Bego~na Gonza´lez-Garc´ıa,c Henri P. A. Nouwsb
and Agust´ın Costa-Garc´ıa*cThe ﬁrst electrochemical immunosensor (EI) for the detection of
antibodies against deamidated gliadin peptides (DGP) is described
here. A disposable nanohybrid screen-printed carbon electrode
modiﬁed with DGP was employed as the transducer's sensing
surface. Real serum samples were successfully assayed and the results
were corroborated with an ELISA kit. The presented EI is a promising
analytical tool for celiac disease diagnosis.Celiac disease (CD) is caused by a genetically determined
specic immune response to antigens present in gluten. Glia-
dins, namely a-gliadins, are considered as the main agent in the
autoimmune response.1 This immune response may be focused
on a limited region of the a-gliadin component of gluten, and
previous studies have suggested that the generation of epitopes
for recognition by CD4+ T cells requires deamidation of the
protein by tissue transglutaminase (tTG).2 tTG catalyzes gliadin
deamidation in the intestinal mucosa of CD patients, resulting
in deamidated gliadin peptides (DGP) which are recognized by
the human leucocyte antigen (HLA) DQ2 receptors of immune
cells. However, it had not previously been shown that candidate
epitope peptides could be generated from gluten in vivo or that
these epitopes were selective products of physiological diges-
tion of gluten by tTG.2
By mimicking the enzymatic gastrointestinal digestion of a
representative a-gliadin it was found that a 33-mer peptide
(LQLQPFPQPQLPYP QPQLPYPQPQLPYPQPQPF; a2-gliadin 56–
88), containing known peptide epitopes, is generated by diges-
tion with intestinal enzymes in vivo and in vitro, producing a
highly stimulatory antigen for CD4+ T cells.3 This fragment was
resistant to further breakdown by luminal proteases andPorto, Rua de Jorge Viterbo Ferreira 228,
ia do Porto, Instituto Polite´cnico do Porto,
, 4200-072 Porto, Portugal
tica, Universidad de Oviedo, Av. Julia´n
: costa@uniovi.es; Fax: +34 985103125;
8intestinal brush-border enzymes due to its high proline content.
The 33-mer contains six partly overlapping copies of three DQ2-
restricted T cell alpha epitopes.4
The frequency of anti-gliadin antibody (AGA) detection for
CD diagnosis has declined because AGA tests lack specicity in
comparison with anti-tTG IgA antibody assays. This disadvan-
tage was overcome by the introduction of DGP as antigen.5
Deamidated gliadin antibodies, especially class G immuno-
globulins, are specic for CD and, therefore, their detection is of
the utmost interest.6
Electrochemical immunosensors (EIs) are interesting alter-
natives to the conventional immunoassays, such as enzyme-
linked immunosorbent assay (ELISA). EIs are simple, easy to
handle and cost-eﬀective analytical tools. The aim of this work
was to develop an EI for the detection of anti-DGP antibodies in
human serum samples. For this purpose, DGPs were immobi-
lized on a single-use carbon/gold nanostructured screen-prin-
ted carbon electrode (SPCE) surface, where they served as the
capture element of the sensing phase. A carrier protein linked
with DGP was chosen instead of a deamidated a-gliadin,
because this peptide, with only 33 amino acids (aa56–88), is very
small (approximately 4 kDa), making its immobilization onto a
solid transducer surface very diﬃcult. Despite the presence of
nanomaterials that contribute to the amplication of the
analytical signal, which is extremely useful when small amounts
of protein material are employed, the referred peptide is too
small to address eﬃcient immunosensing. A carrier fusion
protein with approximately 33 kDa is more likely to be useful,
ensuring the success of the immobilization strategy. In this
work a DGPx4 protein was used as the capture element for the
detection of antibodies specic for deamidated gliadin. This
protein is obtained through the fusion of 2 diﬀerent deami-
dated gliadin peptides and 2 DQ2-epitopes, linked to a carrier
protein.7 The use of a metal nanoparticle–carbon nanostructure
hybrid as the transducer surface allows a synergic eﬀect on each
material property since the hybrid system may have collective
characteristics that are drastically diﬀerent from the individual
components.8This journal is ª The Royal Society of Chemistry 2013
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View Article OnlineAt the moment there are three publications regarding the
use of nanostructured screen-printed electrodes for CD diag-
nosis.9–11However, to the best of our knowledge, at the moment,
there are not any publications regarding the use of EIs for CD
diagnosis using anti-DGP antibodies as serological markers.
Voltammetric analysis was performed with an Autolab
PGSTAT12 (Metrohm Autolab, The Netherlands) potentiostat/
galvanostat interfaced to an AMDK-6 266MHz computer system
and controlled by GPES 4.8 soware (version for Windows 98).
SPCEs and a specic connector were purchased from DropSens
(Spain). Carboxyl modied multi-walled carbon nanotubes
(MWCNTs) were purchased from Nanocyl (Belgium). Standard
tetrachloroaurate (AuCl4
) and silver nitrate were obtained from
Merck (Germany). Biosynth (Switzerland) supplied the 3-indoxyl
phosphate disodium salt (3-IP). A fusionprotein of 4 deamidated
gliadin peptides (33 kDa) (DGPx4: carrier-33merDGP–
26merDGP–DQ2-g1–DQ2-g2) was purchased from Zedira
(Germany). Goat anti-human IgG (Fc specic) conjugated with
alkaline phosphatase (anti-H-IgG–AP) was purchased from
Sigma (Spain). The sensor was assayed with anonymous serum
samples collected in the “Hospital Universitario Central de
Asturias” (Spain), which were previously analysed with a VARE-
LISA Gliadin IgG Antibodies ELISA kit from Phadia (Germany).
Ultrapure water obtained with a Millipore Direct-Q purica-
tion system from Millipore Ibe´rica S.A. (Spain) was used
throughout this work. All chemicals employed were of analytical
reagent grade.
Single-use SPCEs were modied with 4 mL of a 0.1 mg mL1
MWCNT dispersion and the SPCEs were le to dry at room
temperature until complete evaporation of the solvent. Then, the
SPCE–MWCNT-modied electrodes were carefully washed with
water and dried at room temperature. The coating process
was followed by in situ electrochemical deposition of gold
nanoparticles (NPAus) by applying a constant current intensity
of5 mA for 60 s in an acidic 0.1mMAuCl4 solution,12 resulting
in a nanohybrid transducer surface (SPCE–MWCNT–NPAus).
The immunosensor's construction and detection strategy is
presented in Fig. 1 and consisted of the following steps:
– The SPCE–MWCNT–NPAus working electrode was coated
with 10 mL of a 0.30 mg mL1 DPGx4 solution and le to incubate
overnight at 4 C.
– The electrode was then washed with a 0.1 M Tris–HNO3 pH
7.2 buﬀer.
– Free surface sites were blocked with 40 mL of a 2% bovine
serum albumin (BSA) solution for 30 min.Fig. 1 Schematic representation of the immunosensing strategy for the detection
This journal is ª The Royal Society of Chemistry 2013– The immunosensor was incubated with human serum
samples for 60 min followed by a washing step with a 0.1 M
Tris–HNO3 pH 7.2 buﬀer containing 2 mM Mg(NO3)2.
– The immunosensor was incubated with an anti-human
immunoglobulin G labeled with alkaline phosphatase (anti-H-
IgG–AP) (1 : 50 000) solution (40 mL) for 60min and washed with
a 0.1 M Tris pH 9.8 buﬀer containing 20 mM Mg(NO3)2.
– The enzymatic reaction was carried out by dropping a 40 mL
aliquot of a solution containing 1.0 mM 3-IP and 0.4 mM silver
nitrate on the immunosensor surface. The enzymatic deposi-
tion of metallic silver catalyzed by alkaline phosphatase (AP) has
already been reported.13
– Aer 20 min a cyclic voltammogram was recorded from
0.002 V to +0.4 V, at a scan rate of 50 mV s1, to obtain the
electrochemical oxidation current of the enzymatically depos-
ited silver.
The inuence of the concentrations of the capture element
and the secondary labeled antibody on the analytical signal was
investigated. The best relationship between the analytical and
background signal was achieved for a DPGx4 concentration of
0.30 mg mL1 and a dilution of 1 : 50 000 of the anti-H-IgG–AP.
Free surface sites were eﬀectively blocked with BSA (2%). These
optimized experimental conditions were used for the detection
of the serological marker in real serum samples. Fig. 2 shows
typical cyclic voltammograms obtained for the analysis of anti-
DGP antibodies in positive and negative samples, using the
optimized experimental conditions. There is a signicant
diﬀerence between the analytical signals obtained, especially
for positive samples, in the presence and in the absence of the
capture element (i.e. DGPx4) on the electrode surface, which
indicates that it was correctly immobilized.
Aerwards, the immunosensor was applied for the detection
of the antibodies of interest in real serum samples. For this
purpose, a cut-oﬀ linewas set as the averagepeak current intensity
plus three times the standard deviation obtained for 15 negative
samples of healthy individuals. Ten diﬀerent serum samples
(5 positive and 5 negative), which were previously analyzed using
an ELISA kit, were assayed with the immunosensor for the
detection of anti-DGP IgG antibodies. The results, presented in
Fig. 3, revealed that the EI developed presents a good qualitative
correlation with the reference methods for CD diagnosis.
The results obtained in this study demonstrate the useful-
ness of this new electrochemical immunosensor for the detec-
tion of anti-DPG IgG antibodies, a new serological marker
for CD.of anti-DGP antibodies.
Analyst, 2013, 138, 1956–1958 | 1957
Fig. 2 Cyclic voltammograms obtained for the detection of anti-gliadin deamidated antibodies in positive and negative samples, using a transducer surface with (solid
lines) and without (dashed lines) the capture element (DGPx4) immobilized on the electrode surface. The analytical signal obtained in the absence of a sample was also
investigated. Experimental conditions: DPGx4 0.30 mg mL1, serum samples diluted 1 : 200; anti-H-IgG–AP diluted 1 : 50 000; 3-IP 1.0 mM; Ag+ 0.4 mM. Cyclic vol-
tammetric scans from 0.002 V to +0.4 V at a scan rate of 50 mV s1.
Fig. 3 Evaluation of 5 negative (,) and 5 positive (-) human serum samples for
the detection of IgG immunoglobulins generated against deamidated gliadin
peptides, using the optimized electrochemical immunosensor. Experimental
conditions as in Fig. 2 (average data  standard deviations are indicated (n ¼ 3)).
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View Article OnlineIn comparison with the commercial ELISA kits, this reliable
new EI is a more cost-eﬀective analytical tool. Once the steps of
the immunosensing procedure are reduced, this sensor can be
used directly in a point-of-care testing approach.
In future studies it would also be interesting to use dual-
screen-printed electrodes to endorse the simultaneous detec-
tion of antibodies against DPG (IgG) and tissue trans-
glutaminase (IgA) in order to facilitate diagnostic work-up and
the follow-up of celiac disease.
Acknowledgements
This work was supported by a PhD grant (SFRH/BD/46351/2008)
attributed to Marta M. P. S. Neves by the “Fundaç~ao para a1958 | Analyst, 2013, 138, 1956–1958Cieˆncia e a Tecnologia (FCT)” and the European Social Fund
(ESF).References
1 C. Mitea, PLoS One, 2010, 5, e15637.
2 A. M. Mowat, Lancet, 2003, 361, 1290.
3 L. Shan, Ø. Molberg, I. Parrot, F. Hausch, F. Filiz, G. M. Gray,
L. M. Sollid and C. Khosla, Science, 2002, 297, 2275.
4 S. W. Qiao, E. Bergseng, Ø. Molberg, J. Xia, B. Fleckenstein,
C. Khosla and L. M. Sollid, J. Immunol., 2004, 173, 1757.
5 K. Kaukinen, P. Collin, K. Laurila, T. Kaartinen, J. Partanen
and M. Ma¨ki, Scand. J. Gastroenterol., 2007, 42, 1428.
6 U. Volta, A. Granito, E. Fiorini, C. Parisi, M. Piscaglia,
G. Pappas, P. Muratori and F. B. Bianchi, Dig. Dis. Sci.,
2008, 53, 1582.
7 S. Dørum, S. W. Qiao, L. M. Solli and B. Fleckenstein,
J. Proteome Res., 2009, 8, 1748.
8 Y. Gu, X. Hou, H. Hu, B. Yu(F), L. Wang and F. Zhou, Mater.
Chem. Phys., 2009, 116, 284.
9 M. M. P. S. Neves, M. B. Gonza´lez-Garc´ıa, H. P. A. Nouws and
A. Costa-Garc´ıa, Biosens. Bioelectron., 2012, 31, 95.
10 M. M. P. S. Neves, M. B. Gonza´lez-Garc´ıa, A. Santos-Silva and
A. Costa-Garc´ıa, Sens. Actuators, B, 2012, 163, 253.
11 M. M. P. S. Neves, M. B. Gonza´lez-Garc´ıa, C. Delerue-Matos
and A. Costa-Garc´ıa, Sens. Actuators, B, 2012, DOI: 10.1016/
j.snb.2012.09.019.
12 M. M. P. D. Neves, M. B. Gonza´lez-Garc´ıa, C. Delerue-Matos
and A. Costa-Garc´ıa, Electroanalysis, 2011, 23, 63.
13 P. Fanjul-Bolado, D. Herna´ndez-Santos, M. B. Gonza´lez-
Garc´ıa and A. Costa-Garc´ıa, Anal. Chem., 2007, 79, 5272.This journal is ª The Royal Society of Chemistry 2013
